Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

Adult patients with primary immune thrombocytopenia requiring first-line treatment typically receive corticosteroids, which are associated with low response rates and many potential side effects. In a retrospective analysis of two 6-month, placebo-controlled, phase III trials, corticosteroid use dec...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Michel, Marc, te Boekhorst, Peter A W, Janssens, Ann, Pabinger-Fasching, Ingrid, Sanz, Miguel A, Nie, Kun, Kreuzbauer, Georg
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Maney Publishing 2011
Gaiak:
Hematological Malignancy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3178451/
https://ncbi.nlm.nih.gov/pubmed/21902890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1179/102453311X13025568942005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak